LONDON, Ontario and BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its Cell...
Signed Letter of Intent with ‘Project REEM Ventures’ for Product Development and Commercialization in the Kingdom of Saudi Arabia Renowned Diabetes Expert Dr. Robert Gabbay to Serve as Clinical...
Abundant, richly vascularized and functioning islets observed throughout all chambers of Sernova’s Cell Pouch more than 5 years after islet transplantationHistological data confirmation of healthy...
LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) -- August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology...
BEIJING, Feb. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced the completion by its subsidiary, Sinovac Beijing, of the...
BEIJING, Feb. 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading China-based vaccine manufacturer, announced today that the underwriters of its...
BEIJING, Jan. 20 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading China-based vaccine manufacturer, today announced that it plans to sell, subject to market and other...
BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China's...
BEIJING, Dec. 28 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that Weidong Yin, Chairman, President & CEO...
BEIJING, Dec. 21 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced today that Sinovac was selected by China Business...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.23 | 0.235 | 0.22 | 132911 | 0.22897615 | CS |
4 | -0.005 | -2.12765957447 | 0.235 | 0.26 | 0.215 | 112054 | 0.23155507 | CS |
12 | -0.01 | -4.16666666667 | 0.24 | 0.275 | 0.215 | 103289 | 0.24342842 | CS |
26 | -0.12 | -34.2857142857 | 0.35 | 0.39 | 0.2 | 165516 | 0.25582845 | CS |
52 | -0.45 | -66.1764705882 | 0.68 | 0.73 | 0.2 | 160369 | 0.37255968 | CS |
156 | -1.32 | -85.1612903226 | 1.55 | 1.59 | 0.2 | 131211 | 0.67640073 | CS |
260 | -1.32 | -85.1612903226 | 1.55 | 1.59 | 0.2 | 131211 | 0.67640073 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales